Source link : https://newshealth.biz/health-news/lutikizumab-offers-relief-for-refractory-hs/
Lutikizumab improves clinical responses and pain outcomes in patients with hidradenitis suppurativa after anti-TNF failure in a phase 2 study. Medscape Medical News Source link : https://www.medscape.com/viewarticle/lutikizumab-offers-relief-moderate-severe-hidradenitis-2026a10008dn?src=rss Author : Publish date : 2026-03-19 07:45:00 Copyright for syndicated content belongs to the linked Source.
The post Lutikizumab Offers Relief for Refractory HS first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-19 07:45:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8